Axovant announced Monday that President and COO Marion McCourt would exit “to pursue another opportunity” as part of a major executive shakeup at the beleaguered biotech. Turns out, that opportunity is with Regeneron.Original Article
Axovant COO McCourt jumped from sinking biotech right into Regeneron’s top commercial post
